HSP90AA1 and colorectal carcinoma: Indeed, Hsp90α/ß controls a number of critical signaling pathways involved in angiogenesis, epithelial–mesenchymal transformation, apoptosis resistance, metastasis, and drug resistance [22], which, taken together, lead to poor prognosis in CRC [20,23].